A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/42 (2006.01) A61K 9/20 (2006.01) A61K 31/421 (2006.01)
Patent
CA 2255064
The present invention provides a pharmaceutical formulation for oral administration which is pharmaceutically acceptable, and which produces a desired therapeutic response, in tablet, caplet or other compressed form which comprises the potassium, sodium or Tris salt of oxaprozin, the tablet, caplet or other compressed form of the pharmaceutical formulation generally becoming about 75 % dissolved in phosphate buffer media within about 30 minutes.
L'invention concerne une formulation pharmaceutique conçue pour être administrée oralement, acceptable sur le plan pharmaceutique et produisant une réaction thérapeutique souhaitée; elle se présente sous la forme d'un comprimé contenant du potassium, du sodium ou le sel Tris d'oxaprozine, ce comprimé, ce comprimé-capsule ou cette autre forme comprimée se dissolvant généralement à 75 % dans un milieu contenant un tampon de phosphate en 30 minutes environ.
Adams Mark E.
Desai Subhash
Karim Aziz
Paul Kalidas
Schaaf Douglas J.
G.d. Searle & Co.
Smart & Biggar
LandOfFree
Potassium, sodium and tris oxaprozin salt pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potassium, sodium and tris oxaprozin salt pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium, sodium and tris oxaprozin salt pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1372912